Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: DanZ who wrote (2545)	4/24/2000 6:15:00 PM
From: Mike M	Read Replies (1) \| Respond to of 5582

Dan, Thanks for some yeoman effort. I interpret the results as follows: The judge's decision essentially vacated the death threat and has left a nuisance suit in its place. GUMM may aggressively counter suit and/or settle if QGLY will go away for not much money. I see QGLY as foolishly squandering both companies resources in a law suit vindictive in nature (probably done more in frustration of the knock off food supplements rather than GUMM. Had QGLY succeeded in shutting Zicam down it would not likely have resulted in a significant increase in their sales which have been dwindling for years. Regards, Mike